279 related articles for article (PubMed ID: 29983618)
1. Micro-/nano-sized delivery systems of ginsenosides for improved systemic bioavailability.
Kim H; Lee JH; Kim JE; Kim YS; Ryu CH; Lee HJ; Kim HM; Jeon H; Won HJ; Lee JY; Lee J
J Ginseng Res; 2018 Jul; 42(3):361-369. PubMed ID: 29983618
[TBL] [Abstract][Full Text] [Related]
2. Methods on improvements of the poor oral bioavailability of ginsenosides: Pre-processing, structural modification, drug combination, and micro- or nano- delivery system.
Hu QR; Hong H; Zhang ZH; Feng H; Luo T; Li J; Deng ZY; Chen F
J Ginseng Res; 2023 Nov; 47(6):694-705. PubMed ID: 38107396
[TBL] [Abstract][Full Text] [Related]
3. Biopharmaceutical characters and bioavailability improving strategies of ginsenosides.
Pan W; Xue B; Yang C; Miao L; Zhou L; Chen Q; Cai Q; Liu Y; Liu D; He H; Zhang Y; Yin T; Tang X
Fitoterapia; 2018 Sep; 129():272-282. PubMed ID: 29883635
[TBL] [Abstract][Full Text] [Related]
4. Natural Product Ginsenoside 20(S)-25-Methoxyl-Dammarane-3β, 12β, 20-Triol in Cancer Treatment: A Review of the Pharmacological Mechanisms and Pharmacokinetics.
Kim D; Park M; Haleem I; Lee Y; Koo J; Na YC; Song G; Lee J
Front Pharmacol; 2020; 11():521. PubMed ID: 32425780
[No Abstract] [Full Text] [Related]
5. Effects of particle size reduction combined with β-cyclodextrin on the
Liu C; Yang T; Zhao Z; Liu TC; Li K; Liu J; Zhou P
Food Funct; 2022 Oct; 13(21):10882-10894. PubMed ID: 36222359
[TBL] [Abstract][Full Text] [Related]
6. Production of Minor Ginsenoside CK from Major Ginsenosides by Biotransformation and Its Advances in Targeted Delivery to Tumor Tissues Using Nanoformulations.
Murugesan M; Mathiyalagan R; Boopathi V; Kong BM; Choi SK; Lee CS; Yang DC; Kang SC; Thambi T
Nanomaterials (Basel); 2022 Sep; 12(19):. PubMed ID: 36234555
[TBL] [Abstract][Full Text] [Related]
7. Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies.
Wang H; Zheng Y; Sun Q; Zhang Z; Zhao M; Peng C; Shi S
J Nanobiotechnology; 2021 Oct; 19(1):322. PubMed ID: 34654430
[TBL] [Abstract][Full Text] [Related]
8. Dammarane-type leads panaxadiol and protopanaxadiol for drug discovery: Biological activity and structural modification.
Wang M; Li H; Liu W; Cao H; Hu X; Gao X; Xu F; Li Z; Hua H; Li D
Eur J Med Chem; 2020 Mar; 189():112087. PubMed ID: 32007667
[TBL] [Abstract][Full Text] [Related]
9. Stereoscopic Differences in the Identification, Bioactivity, and Metabolism of C-20 and C-24 Epimeric Ginseng Saponins.
Zhang J; Zhao R; Hou G; Wang Q; Zhao F; Liu Z; Meng Q
Mini Rev Med Chem; 2023; 23(7):804-820. PubMed ID: 36237162
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive and systemic review of ginseng-based nanomaterials: Synthesis, targeted delivery, and biomedical applications.
Balusamy SR; Perumalsamy H; Huq MA; Yoon TH; Mijakovic I; Thangavelu L; Yang DC; Rahimi S
Med Res Rev; 2023 Sep; 43(5):1374-1410. PubMed ID: 36939049
[TBL] [Abstract][Full Text] [Related]
11. Self-microemulsifying drug-delivery system for improved oral bioavailability of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol: preparation and evaluation.
Cai S; Shi CH; Zhang X; Tang X; Suo H; Yang L; Zhao Y
Int J Nanomedicine; 2014; 9():913-20. PubMed ID: 24611008
[TBL] [Abstract][Full Text] [Related]
12. [Research and application of quercetin-loaded nano drug delivery system].
Li SJ; Liao YF; Du Q
Zhongguo Zhong Yao Za Zhi; 2018 May; 43(10):1978-1984. PubMed ID: 29933659
[TBL] [Abstract][Full Text] [Related]
13. Colloidal and vesicular delivery system for herbal bioactive constituents.
Pandey R; Bhairam M; Shukla SS; Gidwani B
Daru; 2021 Dec; 29(2):415-438. PubMed ID: 34327650
[TBL] [Abstract][Full Text] [Related]
14. Insight on structural modification, biological activity, structure-activity relationship of PPD-type ginsenoside derivatives.
Tong Y; Song X; Zhang Y; Xu Y; Liu Q
Fitoterapia; 2022 Apr; 158():105135. PubMed ID: 35101587
[TBL] [Abstract][Full Text] [Related]
15. A literature update elucidating production of Panax ginsenosides with a special focus on strategies enriching the anti-neoplastic minor ginsenosides in ginseng preparations.
Biswas T; Mathur AK; Mathur A
Appl Microbiol Biotechnol; 2017 May; 101(10):4009-4032. PubMed ID: 28411325
[TBL] [Abstract][Full Text] [Related]
16. Ginseng pharmacology: multiple constituents and multiple actions.
Attele AS; Wu JA; Yuan CS
Biochem Pharmacol; 1999 Dec; 58(11):1685-93. PubMed ID: 10571242
[TBL] [Abstract][Full Text] [Related]
17. Advances on hormone-like activity of Panax ginseng and ginsenosides.
Tian M; Li LN; Zheng RR; Yang L; Wang ZT
Chin J Nat Med; 2020 Jul; 18(7):526-535. PubMed ID: 32616193
[TBL] [Abstract][Full Text] [Related]
18. Three new dammarane-type triterpene saponins from the leaves of Panax ginseng C.A. Meyer.
Liu GY; Li XW; Wang NB; Zhou HY; Wei W; Gui MY; Yang B; Jin YR
J Asian Nat Prod Res; 2010 Oct; 12(10):865-73. PubMed ID: 20924900
[TBL] [Abstract][Full Text] [Related]
19. Ginsenosides chemistry, biosynthesis, analysis, and potential health effects.
Christensen LP
Adv Food Nutr Res; 2009; 55():1-99. PubMed ID: 18772102
[TBL] [Abstract][Full Text] [Related]
20. Modern drug delivery strategies applied to natural active compounds.
Puglia C; Lauro MR; Tirendi GG; Fassari GE; Carbone C; Bonina F; Puglisi G
Expert Opin Drug Deliv; 2017 Jun; 14(6):755-768. PubMed ID: 27606793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
